Lisbimet
Lisbimet
LISBIMET has been designed by our experts for the treatment of the Middle Aged Metabolic Syndrome (MAMETS)
This syndrome is related to testosterone, it is estimated that 1% less of this hormone is produced each year from the age of thirty onwards.
This gradual decline often causes men in middle age to have weight and behavioural problems such as nervousness, sleep problems and mood disorders and they are more likely to be overweight.
Another factor to bear in mind is that in benign prostatic hyperplasia, the prostate gland begins to enlarge and symptoms begin to appear which, although not serious, are very annoying, such as the urgent need to urinate or having to urinate during the night.
About this product:
LISBIMET contains extracts of the Ashgawanda plant, which increases testosterone levels and is associated with weight loss, reduced anxiety, increased libido and improved sleep.
In addition, Saw palmetto and Pygeum africanum extracts inhibit the enzyme 5 alpha reductase, which influences the process of prostate enlargement, but they also have anti-inflammatory properties, so that at the same time they reduce prostate inflammation, reducing the chances of prostate cancer developing.
References
- Andrade C, Aswath A, Chaturvedi SK, Srinivasa M, Raguram R. A double-blind, placebo-controlledevaluation of the anxiolytic efficacy of an ethanolic extract of Withania somnifera. Indian J Psychiatry2000, 42(3):295-30
- Chauhan S, Srivastava MK, Pathak AK. Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: A randomized controlled trial. Health Sci Rep. 2022 Jul 20;5(4):e741. doi: 10.1002/hsr2.741. PMID: 35873404; PMCID: PMC9297375.
- Dr. Sanjay Tamoli, Dr. Mahesh Kumar Harit, Dr.Narendra B. Mundhe, Dr. Sudarshan Hande,Ms. Kiran Khatau, Dr. Rajesh Giri, Dr. Swapnali Mahadik, Vinay Pawar, Dr. Ganesh KolheAn Evaluation of Efficacy and Safety of Ashwadaat® botanical extract in
patients with Stress and Insomnia – An Open label, multi center, non-
comparative, interventional, prospective clinical study International Journal For Research In Applied And Natural Science International Journal For Research In Applied And Natural ScienceI| Apr, 2021.Volume-7, Issue-4 - Wankhede, S., Langade, D., Joshi, K. et al. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr12, 43 (2015). https://doi.org/10.1186/s12970-015-0104-9
- Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000 Dec;3(4A):459-72. doi: 10.1017/s1368980000000549. PMID: 11276294.
- Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019 Sep 28;11(9):e5797. doi: 10.7759/cureus.5797. PMID: 31728244; PMCID: PMC6827862.
- Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002;1998(1):CD001044. doi: 10.1002/14651858.CD001044. PMID: 11869585; PMCID: PMC7032619.
- Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2002;(3):CD001423. doi: 10.1002/14651858.CD001423. Update in: Cochrane Database Syst Rev. 2009;(2):CD001423. PMID: 12137626.
- Tacklind J, MacDonald R, Rutks I, Wilt TJ. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Update in: Cochrane Database Syst Rev. 2012;12:CD001423. PMID: 19370565; PMCID: PMC3090655.
- Murdocca M, De Masi C, Pucci S, Mango R, Novelli G, Di Natale C, Sangiuolo F. LOX-1 and cancer: an indissoluble liaison. Cancer Gene Ther. 2021 Nov;28(10-11):1088-1098. doi: 10.1038/s41417-020-00279-0. Epub 2021 Jan 5. PMID: 33402733; PMCID: PMC8571092.
- Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis. 2001 Nov;22(11):1765-73. doi: 10.1093/carcin/22.11.1765. PMID: 11698337.